HR 3561, the PATIENT Act of 2023, requires hospitals, health insurance plans, and pharmacy benefit managers to publicly disclose detailed pricing information for healthcare services and drugs. Hospitals must publish standard charges for 300+ shoppable services, including gross charges, payer-specific negotiated rates, and discounted cash prices, with updates required annually. Health plans must provide real-time information on in-network rates, cost sharing, deductibles, and prior authorization requirements for covered services. The bill establishes enforcement mechanisms, including civil monetary penalties for non-compliance, with fines ranging from $300 per day for small hospitals to $5 million for large hospitals that fail to comply with the transparency requirements.
This bill modifies Medicare's rules for clinical laboratory testing to reduce administrative burdens. It requires the use of statistically valid sampling (instead of full reporting) for "widely available" tests - defined as tests costing under $1,000 per test with over 100 labs performing them - to determine payment rates starting in 2026. The bill also delays reporting deadlines until 2027, updates how labs are defined for payment purposes, and adds annual payment increase caps (2.5% for common tests in 2024-2025, rising to 5% by 2028). These changes directly affect Medicare-participating labs, particularly independent and hospital-based labs conducting common tests.
HR 1755 allows the U.S. President to grant Uzbekistan permanent normal trade relations (NTR) status, removing special tariffs on Uzbek exports entering the U.S. market. It terminates the requirement for annual U.S. reviews of Uzbekistan's trade status under a 1974 law. The change takes effect only after Uzbekistan joins the World Trade Organization (WTO). This directly affects Uzbekistan's exporters by enabling their goods to enter the U.S. under standard tariff rates.
This bill expands Medicare Part B coverage to include specific pharmacist services, directly affecting Medicare beneficiaries and pharmacists who provide these services. It adds new coverage for pharmacist evaluations and treatments related to certain illnesses (like COVID-19, flu, or strep throat) and public health emergencies, requiring payment at 80% of the lesser of actual charge or 85% of physician payment rates (100% during emergencies). The bill also prohibits balance billing for these services, ensuring beneficiaries pay only the standard Medicare copayment. These changes aim to improve access to pharmacist care during health crises while aligning payment with existing physician service frameworks.
The Securing Maritime Data from Communist China Act prohibits the U.S. Department of Defense from entering into or renewing contracts with entities using a Chinese government logistics platform called LOGINK or similar platforms controlled by China. It also bans U.S. port operators and critical infrastructure from sharing data with LOGINK or comparable systems, effective two years after enactment. The bill requires the President to negotiate with key allies - including Japan, South Korea, Australia, and NATO members - to encourage them to stop using such platforms and counter China’s international efforts to spread them. A report to Congress must be submitted within one year detailing these negotiations and assessing potential impacts on military operations and commercial port activities.
HR 1666 extends deadlines for ambulance service reimbursement rules under Medicare. It amends Section 1834(l) of the Social Security Act by changing dates from 2025 to 2028 in two specific provisions: paragraph (12)(A) and paragraph (13)(A). This delay gives ambulance providers additional time to adjust to existing Medicare payment rules. The bill directly affects Medicare-certified ambulance services and the patients relying on ground ambulance care covered by Medicare.
HR 1610 would modernize Medicare coverage for chiropractic care by removing the current restriction that limited beneficiaries to one chiropractic service per visit. It expands coverage to include all services provided by licensed chiropractors within their state-authorized scope, aligning Medicare with VA, military, and private insurance practices. The bill requires chiropractors to complete a Secretary-approved educational webinar to cover non-spinal services, while still allowing payment for spinal manipulation treatments without this requirement. This directly affects Medicare beneficiaries seeking chiropractic care and chiropractors seeking Medicare reimbursement for their services.
HR 1399, the "Protect Children's Innocence Act," prohibits medical gender-affirming care for minors under 18 by making it a class C felony for providers to perform such care. The bill defines gender-affirming care broadly to include surgical procedures, hormone treatments, and certain cosmetic procedures, with exceptions for medical conditions like reproductive cancers or intersex conditions. It prohibits federal funding for gender-affirming care through programs like Medicaid, Medicare, and the Affordable Care Act, and bans such care in federal health facilities. The bill also prevents institutions of higher education from teaching gender-affirming care and adds immigration consequences for individuals who provide such care to minors.
HR 549, the Metastatic Breast Cancer Access to Care Act, removes waiting periods for disability and Medicare coverage for people diagnosed with metastatic breast cancer. Specifically, it amends Social Security Act sections to allow immediate eligibility for disability insurance benefits (eliminating the standard waiting period) and immediate Medicare coverage (waiving the 24-month waiting period) for these patients. The bill directly affects individuals with metastatic breast cancer who would otherwise face delays in accessing critical benefits. These changes apply to applications filed or benefits beginning after the bill's enactment date. The law makes no other policy changes beyond these specific eligibility adjustments.
This bill bans federal funding for abortions in most cases, prohibiting the use of taxpayer money for abortion services or health insurance plans covering abortion. Exceptions allow funding for abortions resulting from rape, incest, or when a pregnancy endangers a woman's life. It requires health insurance plans sold through the Affordable Care Act (ACA) marketplaces to clearly disclose any separate costs for abortion coverage and prohibits ACA subsidies from being used for plans that cover abortion (except in the specified exceptions). The law directly affects federal programs like Medicaid, ACA marketplace plans, and insurers offering health coverage to individuals using federal subsidies.
HJRES 181 is a congressional resolution seeking to block a Department of Labor rule that defined "Employer-Association Health Plans." The bill would prevent this specific rule - published in the Federal Register on April 30, 2024 - from taking effect. It directly affects employers and health plan administrators who use these association-based health coverage models. If passed, the rule would have no legal force, reversing the Labor Department's regulatory definition.
This bill (S 5533) would repeal the Impoundment Control Act of 1974, a federal law that restricts the President's ability to withhold or delay spending approved by Congress. If enacted, it would directly affect the executive branch by removing legal limits on the President's authority to delay or cancel the use of funds that Congress has already appropriated. The key mechanism is a straightforward repeal of the specific law (2 U.S.C. 681 et seq.), eliminating its provisions that required presidential justification for withholding funds. This change would alter the balance of power between Congress and the executive on federal budget execution.
